455 A phase II study of first-line combination chemotherapy with docetaxel and gemcitabine in anthracycline-pretreated, Her-2 negative metastatic breast cancer (MBC)

F.Lenz; F.Beldermann; M.Geberth; G.Bastert; A.Schneeweiss

首页> 外文期刊>European Journal of Cancer Supplements >455 A phase II study of first-line combination chemotherapy with docetaxel and gemcitabine in anthracycline-pretreated, Her-2 negative metastatic breast cancer (MBC)

【24h】

455 A phase II study of first-line combination chemotherapy with docetaxel and gemcitabine in anthracycline-pretreated, Her-2 negative metastatic breast cancer (MBC)

机译：455在蒽环类药物预处理的Her-2阴性转移性乳腺癌（MBC）中，多西他赛和吉西他滨一线联合化疗的II期临床研究

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2003年第5期|共1页
作者
F.Lenz; F.Beldermann; M.Geberth; G.Bastert; A.Schneeweiss;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 455 A phase II study of first-line combination chemotherapy with docetaxel and gemcitabine in anthracycline-pretreated, Her-2 negative metastatic breast cancer (MBC) [J] . F.Lenz, F.Beldermann, M.Geberth, European Journal of Cancer Supplements . 2003,第5期

机译：455在蒽环类药物预处理的Her-2阴性转移性乳腺癌（MBC）中，多西他赛和吉西他滨一线联合化疗的II期临床研究
2. Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group. [J] . Mavroudis D, Malamos N, Alexopoulos A, Annals of oncology: official journal of the European Society for Medical Oncology . 1999,第2期

机译：接受蒽环类药物预处理的转移性乳腺癌患者使用多西他赛和吉西他滨进行挽救性化疗：一项多中心II期试验。希腊乳腺癌合作组织。
3. 2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC) [J] . N.Tubiana-Mathieu, P.Bougnoux, D.Becquart, European Journal of Cancer Supplements . 2007,第4期

机译：2130海报更新了一项国际II期研究的分析，该研究评估了口服长春瑞滨和卡培他滨的全口服组合作为一线化疗治疗HER2阴性转移性乳腺癌（MBC）
4. Gemcitabine + Cisplatin Combination Electrochemotherapy for Triple Negative Breast Cancers: An in vitro Model Study [C] . R. Sundararajan, V. Raman, V. Masterson World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food Environmental Technologies . 2016

机译：Gemcitabine +顺铂组合电化学疗法三重阴性乳腺癌：体外模型研究
5. Enhancement of Gemcitabine and Paclitaxel Uptake and Retention in Metastatic Cancer Cells: A Novel Targeted Combination Delivery Approach to Eliminate Breast Cancer in Blood and Lymph [D] . Yu, Jesse. 2020

机译：吉西他滨和紫杉醇吸收的增强和转移性癌细胞的保留：一种小型靶向组合递送方法，消除血液和淋巴中的乳腺癌
6. Quality of life outcomes including neuropathy-associated scale from a phase II multicenter randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11) [O] . Ji-Yeon Kim, Seri Park, Seock-Ah Im, 2019

机译：生活质量的结果包括II期多中心埃瑞布林联合吉西他滨与紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的神经病相关评分的随机临床试验：韩国癌症研究小组试验（KCSG BR13-11）
7. Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer [O] . Zoli Wainer, Zumaglini Federica, Oliverio Giovanni, 2008

机译：两种基于吉西他滨和多西他赛的组合作为转移性非小细胞肺癌的一线化疗的随机II期研究

455 A phase II study of first-line combination chemotherapy with docetaxel and gemcitabine in anthracycline-pretreated, Her-2 negative metastatic breast cancer (MBC)

著录项

相似文献

相关主题

期刊订阅